Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6854562 | 0.99 | NPC1 (0.40) | NPC1RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL6858737 | 0.89 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL6858729 | 0.85 | NPC1 (0.46) | NPC1RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL6838377 | 0.81 | NPC1 (0.37) | NPC1RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL9141866 | 0.81 | NR5A1 (0.50) | NR5A1LTA4H | |
| SCHEMBL6534705 | 0.80 | NPC1 (0.39) | NPC1RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL6838370 | 0.79 | NPC1 (0.46) | NPC1RAB9ASMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL6838367 | 0.79 | NPC1 (0.46) | NPC1RAB9ASMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL6839212 | 0.79 | NPC1 (0.41) | NPC1RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL6839218 | 0.79 | NPC1 (0.41) | NPC1RAB9AMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6783812-B2 | USEFUL IN THE MANUFACTURE OF OPTICAL DEVICES; STABILITY | DISPLAYTECH, INC. | 2004-08-31 | — | — | US | disclosed |
| US-6759101-B2 | USEFUL IN FERROELECTRIC LIQUID CRYSTAL COMPOSITIONS; USE TO LOWER MELTING POINT OR LOWER FREEZING POINT, OF LIQUID CRYSTAL COMPOSITIONS | DISPLAYTECH, INC. | 2004-07-06 | — | — | US | disclosed |
| US-6737124-B2 | ESPECIALLY DISILANES | DISPLAYTECH, INC. | 2004-05-18 | — | — | US | disclosed |
| US-20030003245-A1 | Liquid crystal compounds having a silane tail with a perfluoroalkyl terminal portion | CITIZEN FINETECH MIYOTA CO., LTD. (JP) | 2003-01-02 | — | — | US | disclosed |
| US-20020195585-A1 | Liquid crystalline materials containing perfluoroalkyl and alkenyl tail groups | CITIZEN FINEDEVICE CO., LTD. (JP) | 2002-12-26 | — | — | US | disclosed |
| US-20020130299-A1 | Alkyl silane liquid crystal compounds | CITIZEN FINEDEVICE CO., LTD. (JP) | 2002-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030003245-A1 | Liquid crystal compounds having a silane tail with a perfluoroalkyl terminal portion | FFAR3, FFAR1, LPAR1 | NPC1 393/4885RAB9A 1832/4885MEN1 3636/4885 |
| US-20020130299-A1 | Alkyl silane liquid crystal compounds | SMURF1, SMURF2, DSTN | NPC1 2373/4885RAB9A 3181/4885MEN1 3350/4885 |
| US-20020195585-A1 | Liquid crystalline materials containing perfluoroalkyl and alkenyl tail groups | ELOVL3, LPCAT1, FABP4 | NPC1 1442/4885RAB9A 3617/4885MEN1 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.